Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment | Tata India Pharma & HealthCare Fund NAV Today [32.06], Performance & History

Equity Sectoral Thematic Regular

Regular

Direct

3 Year Absolute Returns

72.15% ↑

NAV (₹) on 16 Jul 2026

32.06

1 Day NAV Change

0.27%

Risk Level

Very High Risk

Rating

Tata India Pharma & HealthCare Fund is a Equity mutual fund categorized under Sector, offered by Tata Asset Management Ltd.. Launched on 04 Dec 2015, investors can start with a minimum SIP of ₹100 or ... Read more

NAV History

Fund Details

Min. SIP Amount

₹150

Inception Date

04 Dec 2015

Min. Lumpsum Amount

₹ 5,000

Fund Age

10 Yrs

AUM

₹ 1,455.16 Cr.

Benchmark

BSE Healthcare Total Return

Expense Ratio

2.25%

Scheme Type

Open Ended

Exit Load

0.25%

Returns Calculator

Investment amount per month

₹1,000

Over the past

Would have become

On total investment of

*Calculation based on past performance of this fund.

Asset Allocation

AUM

₹ 1,455.16 Cr

Equity

584.4%

Money Market & Cash

15.6%

Sector Holdings

Sectors	Weightage
Pharmaceuticals	62.43%
Hospitals & Medical Services	29.59%
Agro Chemicals/Pesticides	4.17%
Cash	2.34%
Personal Care	1.23%
CBLO/Reverse Repo	0.24%

See All

Stock Holdings

Name	Weightage	Value (in Cr.)	Sector
SUN PHARMACEUTICAL INDUSTRIES LTD	8.51%	₹ 123.89	Pharmaceuticals
MAX HEALTHCARE INSTITUTE LTD	5.68%	₹ 82.71	Hospitals & Medical Services
HEALTHCARE GLOBAL ENTERPRISES LTD	5.52%	₹ 80.31	Hospitals & Medical Services
DIVI LABORATORIES LTD	5.12%	₹ 74.55	Pharmaceuticals
ABBOTT INDIA LTD	4.97%	₹ 72.38	Pharmaceuticals
CIPLA LTD	4.77%	₹ 69.44	Pharmaceuticals
APOLLO HOSPITALS ENTERPRISE LTD	4.61%	₹ 67.15	Hospitals & Medical Services
RAINBOW CHILDRENS MEDICARE LTD	4.42%	₹ 64.25	Hospitals & Medical Services
DR REDDYS LABORATORIES LTD	4.26%	₹ 62.04	Pharmaceuticals
GLAXOSMITHKLINE PHARMACEUTICALS LTD	4.12%	₹ 60	Pharmaceuticals
MANKIND PHARMA LTD	3.85%	₹ 56.01	Pharmaceuticals
FORTIS HEALTHCARE LTD	3.35%	₹ 48.74	Hospitals & Medical Services
BAYER CROPSCIENCE LTD	3.20%	₹ 46.56	Agro Chemicals/Pesticides
LUPIN LTD	2.81%	₹ 40.83	Pharmaceuticals
SYNGENE INTERNATIONAL LTD	2.73%	₹ 39.75	Pharmaceuticals
ALKEM LABORATORIES LTD	2.64%	₹ 38.47	Pharmaceuticals
SAI LIFE SCIENCES LTD	2.53%	₹ 36.88	Pharmaceuticals
PFIZER LTD	2.50%	₹ 36.37	Pharmaceuticals
FDC LTD	2.34%	₹ 34.12	Pharmaceuticals
CASH / NET CURRENT ASSET	2.34%	₹ 33.59	Others
GLOBAL HEALTH LTD	2.32%	₹ 33.70	Hospitals & Medical Services
PROCTER & GAMBLE HEALTH LTD	1.79%	₹ 26.02	Pharmaceuticals
CONCORD BIOTECH LTD	1.76%	₹ 25.63	Pharmaceuticals
DR. LAL PATH LABS LTD	1.64%	₹ 23.88	Hospitals & Medical Services
AJANTA PHARMA LTD	1.60%	₹ 23.29	Pharmaceuticals
NEULAND LABORATORIES LTD	1.60%	₹ 23.31	Pharmaceuticals
SANOFI INDIA LTD	1.53%	₹ 22.23	Pharmaceuticals
METROPOLIS HEALTHCARE LTD	1.45%	₹ 21.16	Hospitals & Medical Services
GILLETTE INDIA LTD	1.23%	₹ 17.89	Personal Care
TORRENT PHARMACEUTICALS LTD	1.02%	₹ 14.82	Pharmaceuticals
SUMITOMO CHEMICAL INDIA LTD	0.97%	₹ 14.13	Agro Chemicals/Pesticides
JUBILANT PHARMOVA LTD	0.91%	₹ 13.22	Pharmaceuticals
DR. AGARWALS HEALTH CARE LTD	0.60%	₹ 8.75	Hospitals & Medical Services
IPCA LABORATORIES LTD	0.58%	₹ 8.51	Pharmaceuticals
ZIM LABORATORIES LTD	0.49%	₹ 7.09	Pharmaceuticals
REPO	0.24%	₹ 3.48	Others

See All

Returns

	Annualised returns
	9M	1Y	2Y	3Y
Fund returns	4.00%	3.71%	7.86%	19.85%
Category returns	3.36%	4.49%	6.16%	22.44%

Fund Objective

The investment objective of the scheme is to seek long term capital appreciation by investing at least 80% of its net assets in equity/equity related instruments of the companies in the pharma & ... Read more

AMC Details

Name

Tata Asset Management Ltd.

Date of Incorporation

30 Jun 1995

CEO

Mr. Anand Vardarajan

CIO

Mr. Rahul Singh

Type

Pvt.Sector-Indian

Address

1903, B-Wing, Parinee Crescenzo, G-Block, Bandra Kurla Complex, Bandra East, Mumbai, Maharashtra, India - 400051

Website

http://www.tatamutualfund.com

[email protected]

Top Funds from Equity - Sectoral/Thematic

Scheme Name	NAV	Returns 1Y 3Y 5Y			AUM (Cr)	Expense Ratio	Risk Meter
Nippon India Taiwan Equity fund - Direct Plan Sector Direct	₹34.94	150.72%	264.87%	0.00%	₹1,192	1.30%	Very High
Nippon India Taiwan Equity fund - Direct Plan Sector Direct	₹34.94	150.72%	264.87%	0.00%	₹1,192	1.30%	Very High
Nippon India Taiwan Equity fund - Direct Plan Sector Direct	₹34.94	150.72%	264.87%	0.00%	₹1,192	1.30%	Very High
Nippon India Taiwan Equity Fund Sector Regular	₹32.69	147.32%	250.04%	0.00%	₹1,192	2.60%	Very High
Nippon India Taiwan Equity Fund Sector Regular	₹32.69	147.32%	250.04%	0.00%	₹1,192	2.60%	Very High
Nippon India Taiwan Equity Fund Sector Regular	₹32.69	147.32%	250.04%	0.00%	₹1,192	2.60%	Very High
HDFC Defence Fund - Direct Plan Sector Direct	₹29.95	17.92%	180.60%	0.00%	₹10,529	0.87%	Very High
HDFC Defence Fund - Direct Plan Sector Direct	₹29.95	17.92%	180.60%	0.00%	₹10,529	0.87%	Very High
HDFC Defence Fund - Direct Plan Sector Direct	₹29.95	17.92%	180.60%	0.00%	₹10,529	0.87%	Very High
HDFC Defence Fund Sector Regular	₹28.93	16.75%	171.42%	0.00%	₹10,529	1.80%	Very High

Top Funds from Tata Asset Management Ltd.

Scheme Name	NAV	Returns 1Y 3Y 5Y			AUM (Cr)	Expense Ratio	Risk Meter
Tata India Pharma & HealthCare Fund - Direct Plan Sector Direct	₹39.33	9.40%	87.04%	101.04%	₹1,455	0.94%	Very High
Tata India Pharma & HealthCare Fund - Direct Plan Sector Direct	₹38.05	5.85%	80.96%	94.51%	₹1,455	0.94%	Very High
Tata India Pharma & HealthCare Fund - Direct Plan Sector Direct	₹38.05	5.85%	80.96%	94.51%	₹1,455	0.94%	Very High
Tata India Pharma & HealthCare Fund Sector Regular	₹33.33	7.84%	78.99%	86.66%	₹1,455	2.25%	Very High
Tata India Pharma & HealthCare Fund Sector Regular	₹32.06	3.71%	72.15%	79.52%	₹1,455	2.25%	Very High
Tata Mid Cap Fund - Direct Plan Diversified Direct	₹533.80	6.80%	70.35%	120.10%	₹5,868	0.84%	Very High
Tata Resources & Energy Fund - Direct Plan Sector Direct	₹58.65	8.13%	68.89%	95.64%	₹1,361	0.85%	Very High
Tata Nifty Midcap 150 Momentum 50 Index Fund - Direct Plan Index Direct	₹18.42	-0.24%	66.86%	0.00%	₹1,202	0.49%	Very High
Tata Nifty Midcap 150 Momentum 50 Index Fund - Direct Plan Index Direct	₹18.42	-0.24%	66.86%	0.00%	₹1,202	0.49%	Very High
Tata Nifty Midcap 150 Momentum 50 Index Fund - Direct Plan Index Direct	₹18.42	-0.24%	66.86%	0.00%	₹1,202	0.49%	Very High

FAQs

What is the current NAV of Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment?

The current Net Asset Value (NAV) of Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment is ₹32.06 as of 16 Jul 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.

What is the fund size (AUM) of Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment?

The Assets Under Management (AUM) of Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment is ₹1,455.16 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.

What are the historical returns of Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment?

Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment has delivered returns of 3.71% (1 Year), 19.85% (3 Year), 12.41% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.

What is the risk level of Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment?

Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.

What is the minimum investment amount for Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment?

The minimum lumpsum investment required for Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment is ₹5,000. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹150, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article